Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nation

Abstract Background Migraine progression, particularly from episodic to chronic migraine (CM), increases disease burden and healthcare costs. Understanding the new concept of “Medication Underuse Headache” should encourage the health care provider to consider early intervention with calcitonin gene-...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Wanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Auranee Trisataya, Sekh Thanprasertsuk, Alan Rapoport
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-01-01
סדרה:	The Journal of Headache and Pain
נושאים:	Medication underuse headache Galcanezumab Very low frequency episodic migraine Preventive medication
גישה מקוונת:	https://doi.org/10.1186/s10194-025-01952-1
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!